| 代码 | 名称 | 相关 | 收盘价 | 张浩喧 | 买方 0 | 卖方 0 | 机构买入 | 机构氨出 | 机构买入 | | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | | | | | | | 机构做 | 机构改 | 高额(万) | 点额(万) | 净额(万) 0 � | | 603063 天望电气 明细 股吧 37.90 | | | | 10.01% | | | 45706.00 | 0.00 | 45706.00 | | 买入金额最大的前5名 | | | | | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 序号 | 交易营业部名称 | | | 买入金额(万) | 占总成交比例 | 卖出金额(万) | 占总成交比例 | 争额(万)2 | | 1 | 户展通专用 | 371次 39.89% | C | 47928.97 | 7.95% | | | 47928.97 | | 2 | 机构专用 | 1414次 43.42% | ▲ | 45706 ...

Group 1: Drug Development and Clinical Trials - Heng Rui Medicine received clinical trial approval for HRS-5041, a new AR-PROTAC small molecule for prostate cancer treatment, showing significant degradation of AR proteins and potential to overcome resistance compared to second-generation AR inhibitors [1] - Huahai Pharmaceutical's HB0043, the world's first dual-target antibody for IL-17A and IL-36R, received clinical trial approval, aimed at treating various autoimmune diseases with a development cost of approximately 69.09 million yuan [4] - Microchip Biotech's CS231295, a selective AuroraB inhibitor, received FDA approval for a Phase I clinical trial targeting advanced solid tumors, with no similar drugs currently in clinical trials globally [5] - Shutai Shen's BDB-001 injection for ANCA-associated vasculitis showed significant clinical advantages in hormone reduction during Phase I/II trials, prompting plans for Phase III trials [6] - Yahui Medicine's APL-1401 for moderate to severe active ulcerative colitis showed positive preliminary results in Phase Ib trials, with plans for further evaluation in a larger patient group [8] Group 2: Corporate Actions and Financial Updates - Wanhua Chemical's major shareholder plans to reduce its stake by up to 0.54%, equivalent to 17 million shares, due to personal financial needs, with the reduction period set from August 22, 2025, to November 21, 2025 [2] - Shanying International plans to establish a partnership valued at 2.977 billion yuan to attract long-term investors, enhancing its sustainable development and core competitiveness [3] - Ding Tong Technology's controlling shareholder intends to transfer 3% of the company's shares, amounting to 417,600 shares, for personal financial needs [7] - Aokang plans to issue convertible bonds to raise no more than 1 billion yuan for high-end printed circuit board projects [9] - Ankai Micro launched the AK1037 series low-power lock control SoC chip, enhancing its product matrix in smart lock solutions [10]

Summary of Key Points Core Viewpoint - On July 31, a total of 39 stocks were involved with institutional investors, with 21 stocks showing net buying and 18 stocks showing net selling [1] Institutional Buying and Selling - The top three stocks with the highest net buying by institutions were: - Industrial Fulian with a net buying amount of 1.498 billion [1] - Hewei Electric with a net buying amount of 457 million [1] - Yidian Tianxia with a net buying amount of 173 million [1] - The top three stocks with the highest net selling by institutions were: - Dongxin Co., Ltd. with a net outflow amount of 119 million [1] - New Henghui with a net outflow amount of 71.62 million [1] - Gongchuang Turf with a net outflow amount of 47.31 million [1]

Core Viewpoint - The stock of Hewei Electric (603063.SH) experienced an abnormal trading fluctuation, with a cumulative closing price increase exceeding 20% over three consecutive trading days from July 29 to July 31, 2025 [1] Company Overview - Hewei Electric's main products remain unchanged, which include wind power generation products, photovoltaic power generation products, energy storage products, electrical transmission products, hydrogen power supply products, and power quality products [1] - The company has noted market rumors regarding its involvement in HVDC products; however, it currently does not have any HVDC products [1]

证券代码：603063 证券简称：禾望电气 公告编号：2025-070 深圳市禾望电气股份有限公司 股票交易异常波动公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： 深圳市禾望电气股份有限公司（以下简称"公司"）股票于 2025 年 7 月 29 日、7 月 30 日、7 月 31 日连续三个交易日收盘价格涨幅偏离值累计超过 20%， 根据《上海证券交易所交易规则》的有关规定，属于股票交易异常波动的情形。 经公司自查，并书面问询公司控股股东及实际控制人，截至本公告披露 日，公司、控股股东及实际控制人不存在应披露而未披露的重大信息。 经公司自查，公司主营产品未发生变动，主要产品覆盖风力发电产品、 光伏发电产品、储能产品、电气传动产品、制氢电源产品、电能质量产品等。公 司关注到有市场传闻称公司涉及 HVDC 产品，目前公司尚无 HVDC 产品。敬请 广大投资者充分了解二级市场交易风险，切实提高风险意识，防范市场炒作，理 性决策，审慎投资。 公司存在高级管理人员减持股份计划，具体详见公司于 2025 年 7 月 ...

Core Viewpoint - Hezhong Electric (603063.SH) announced that its stock price experienced an abnormal fluctuation, with a cumulative increase of over 20% in closing prices over three consecutive trading days from July 29 to July 31, 2025 [1] Company Overview - The company confirmed that there have been no changes to its main products, which include wind power generation products, photovoltaic power generation products, energy storage products, electric drive products, hydrogen power products, and power quality products [1] - The company noted market rumors regarding its involvement in HVDC products; however, it clarified that it currently does not have any HVDC products [1] Market Awareness - The company urged investors to be aware of the risks associated with secondary market trading, emphasizing the importance of risk awareness to prevent market speculation and to make rational investment decisions [1]

Core Viewpoint - The company, Hewei Electric (603063), experienced a significant stock price fluctuation, with a cumulative closing price deviation exceeding 20% over three consecutive trading days from July 29 to July 31, 2025, indicating abnormal trading activity [1] Company Information - The company confirmed that there are no undisclosed significant information after self-examination and inquiries with major shareholders and actual controllers [1] - The main products of the company remain unchanged, covering wind power generation products, photovoltaic power generation products, energy storage products, electric drive products, hydrogen power products, and power quality products [1] - The company noted market rumors regarding its involvement in HVDC products; however, it currently does not have any HVDC products [1] - There is a plan for senior management to reduce their shareholdings [1] - The company advises investors to make rational investment decisions and be aware of investment risks [1]

Group 1 - Institutional trading saw 36 stocks listed, with 20 experiencing net buying and 16 net selling [1] - The top three stocks with the highest institutional buying were: Industrial Fulian (1.498 billion), Hewei Electric (457 million), and Beifang Changlong (241 million) [1] - Industrial Fulian's stock price increased by 6.04%, while Hewei Electric rose by 10.01% [2] Group 2 - Hewei Electric had a net institutional purchase of 457 million [3] - Ansem announced a partnership with NVIDIA to promote the transition to an 800V direct current (VDC) power supply architecture, enhancing efficiency and sustainability in AI data centers [3] - The company specializes in high-capacity power products applicable to AI data center power systems [3] Group 3 - Meta reported second-quarter earnings that exceeded expectations, leading to a stock price increase of 10% post-announcement, indicating strong growth in its advertising business [3] - Microsoft and Meta both reported better-than-expected earnings and increased capital expenditures, contributing to NVIDIA's stock reaching new highs [3] - The company is a global partner of NVIDIA's Blackwell platform [3]

Core Insights - On July 31, institutional investors showed significant activity in the stock market, with a total of 39 stocks being involved, of which 21 experienced net buying and 18 faced net selling [1][2]. Group 1: Institutional Buying - The top three stocks with the highest net buying by institutions were Industrial Fulian, Hewei Electric, and Yidian Tianxia, with net buying amounts of 1.498 billion, 457 million, and 173 million respectively [1][2]. - Other notable stocks with institutional net buying included Anglikang (172 million), Beifang Changlong (127 million), and Huilv Ecology (76.81 million) [2]. Group 2: Institutional Selling - The top three stocks with the highest net selling by institutions were Dongxin Co., New Henghui, and Gongchuang Turf, with net selling amounts of 119 million, 71.62 million, and 47.31 million respectively [1][3]. - Additional stocks that faced net selling included Hai Sen's Industry (2.37 million) and Ji Shi Media (4.51 million) [3].

Investment Rating - The industry investment rating is "Positive (Maintain)" [5] Core Insights - Overseas cloud service providers (CSPs) have revised their capital expenditure (CAPEX) expectations upwards, leading to an increase in data center construction activity. Major companies like Microsoft, Google, and Meta have all raised their CAPEX forecasts for 2025, driven by strong AI demand [7] - The importance of high-efficiency, high-density, and high-stability power supply systems is increasing as the industry transitions from traditional computing to AI-driven computing. This shift necessitates continuous upgrades in power supply technology across various stages of the power chain [7] - The overseas AIDC (AI Data Center) market is experiencing a boom, with companies like Delta and Vertiv holding significant technological advantages. Domestic companies are expected to benefit from this trend as they close the technology gap and gain access to the overseas market [7] Summary by Sections Investment Recommendations and Targets - The report suggests focusing on companies that are likely to benefit from the rising demand for AIDC power supply, including Megmeet (002851), Hezhong Electric (603063), Newray (300593), Tonghe Technology (300491), Oulu Tong (300870), and Zhongheng Electric (002364) [7] - For AIDC power supply support, companies such as Jinpan Technology (688676), Mingyang Electric (301291), Weiteng Electric (688226), and Liangxin Co. (002706) are recommended for attention [7]